Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | FABP3 | P05413 | 9/20 | 0.52 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octanedioate SCHEMBL8613631 | 1.00 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL9851840 | 1.00 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Sebacic Acid SCHEMBL9851833 | 1.00 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Azelaic Acid SCHEMBL9318399 | 1.00 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Octanedioate SCHEMBL29373838 | 0.97 | CA1 (0.52) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Pimelic Acid SCHEMBL29371665 | 0.97 | CA1 (0.52) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Sebacic Acid SCHEMBL29374000 | 0.97 | CA1 (0.52) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Azelaic Acid SCHEMBL29371439 | 0.97 | CA1 (0.52) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Adipic Acid SCHEMBL415306 | 0.96 | CA1 (0.58) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Octanedioate SCHEMBL8386996 | 0.93 | CA1 (0.55) | CA1FABP3FFAR3HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040890-A | Pyroelectric polymer composite material and preparation method thereof | 都江堰市天兴硅业有限责任公司 | 2025-05-27 | — | — | CN | claimed |
| WO-2025029611-A1 | THERAPIES FOR DISEASES OF COPPER METABOLISM | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2012096655-A1 | COMPOSITIONS FOR TREATING CHRONIC VIRAL INFECTIONS | ANG SAM POON (US) | 2012-07-19 | — | — | WO | claimed |
| US-20120082720-A1 | Compositions For Treating Chronic Viral Infections | ANG SAM POON (US) | 2012-04-05 | — | — | US | claimed |
| US-20090041856-A1 | Methods for promoting hair growth | MURAD, INC. | 2009-02-12 | — | — | US | claimed |
| US-7452527-B2 | Methods of promoting hair growth | MURAD, INC. (US) | 2008-11-18 | — | — | US | claimed |
| US-20050241658-A1 | Composition to reduce or quit smoking addiction | LLOYDS INTERNATIONAL CREDIT, LLC | 2005-11-03 | — | — | US | claimed |
| US-6845777-B2 | Composition to reduce or quit smoking addiction | LLOYDS INTERNATIONAL CREDIT, LLC | 2005-01-25 | — | — | US | claimed |
| WO-2004087085-A1 | METHODS OF PROMOTING HAIR GROWTH | MURAD HOWARD (US) | 2004-10-14 | — | — | WO | claimed |
| US-6800292-B1 | FREE RADICAL NEUTRALIZATION; INCLUDES MOISTURIZERS | UNILEVER NV (NL) | 2004-10-05 | — | — | US | claimed |
| US-20020127256-A1 | Compositions and methods for treating dermatological disorders | MURAD HOWARD (US) | 2002-09-12 | — | — | US | claimed |
| EP-0812824-B1 | Process for preparing N-substituted maleimides | DAIHACHI CHEM IND (JP) | 2001-04-04 | — | — | EP | claimed |
| US-5972999-A | MIXTURE OF A SUGAR, ANTIOXIDANT AND AMINO ACID | UNILEVER NV (NL) | 1999-10-26 | — | — | US | claimed |
| US-5939076-A | Composition and method for treating or alleviating migraine headaches | ALLOCCA TECHICAL, INC. (US) | 1999-08-17 | — | — | US | claimed |
| WO-1999023881-A1 | COMPOSITION AND METHOD FOR PREVENTING OR ALLEVIATING MIGRAINE HEADACHES | ALLOCCA TECHNICAL, INC. (US) | 1999-05-20 | — | — | WO | claimed |
| US-5804168-A | PRIMARY ANTIOXIDANT, ANTIINFLAMMATORY AGENT, AND IMMUNITY-BOOSTING COMPONENT | UNILEVER NV (NL) | 1998-09-08 | — | — | US | claimed |
| US-5804594-A | APPLYING A COMPOSITION INCLUDING A SUGAR COMPOUND THAT IS CONVERTED TO A GLYCOSAMINOGLYCAN TO THICKEN SKIN, A PRIMARY ANTIOXIDANT TO INHIBIT FORMATION OF COLLAGENASE AND ELASTASE AND AT LEAST ONE AMINO ACID | UNILEVER NV (NL) | 1998-09-08 | — | — | US | claimed |
| US-5741913-A | REACTING MALEIC ANHYDRIDE WITH A PRIMARY AMINE IN MIXTURE OF PROTIC POLAR AND NONPOLAR SOLVENTS IN PRESENCE OF ACID CATALYST AND POLYMERIZATION INHIBITOR, EFFICIENCY | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 1998-04-21 | — | — | US | claimed |
| US-5723075-A | HEAT RESISTANT ABSORBERS WITH RESINS FOR SHIELDS | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 1998-03-03 | — | — | US | claimed |
| EP-0812824-A1 | Process for preparing N-substituted maleimides | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-12-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120082720-A1 | Compositions For Treating Chronic Viral Infections | HAVCR2, FABP1, LIPC | CA1 4698/4885FABP3 73/4885FFAR3 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.